Search

Search bills, members, committees and pages...

Sign In

BIOTECHNOLOGY INNOVATION ORGANIZATION

PreviousNext

95 federal lobbying filings, 2023 to 2026.

BIOTECHNOLOGY INNOVATION ORGANIZATION is a client on 95 federal lobbying filings, 2023 to 2026, reporting $4.1M across them. Represent and support policies on behalf of Biotechnology Companies and Innovators Based in District of Columbia.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.

Firms

9 it has hired, by filings.

RegistrantFilingsReported
BIOTECHNOLOGY INNOVATION ORGANIZATION16—
AKIN GUMP STRAUSS HAUER & FELD14$880K
AVOQ, LLC14$1.1M
BGR GOVERNMENT AFFAIRS14$840K
ARENTFOX SCHIFF LLP11$10K
TODD STRATEGY GROUP10$600K
DLA PIPER LLP (US)6$300K
VALCOUR LLC6$220K
SL STRATEGIES, LLC4$160K

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
202612$620K$4M
202527$1.1M$5.6M
202427$1.2M$8.5M
202329$1.2M$11.2M

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
HCRHealth Issues84
TRDTrade (domestic/foreign)38
MMMMedicare/Medicaid34
BUDBudget/Appropriations28
TAXTaxation/Internal Revenue Code27
MEDMedical/Disease Research/Clinical Labs22
FOOFood Industry (safety, labeling, etc.)21
SMBSmall Business18
CPTCopyright/Patent/Trademark16
HOMHomeland Security16
ANIAnimals14
AGRAgriculture12
CHMChemicals/Chemical Industry12
ENGEnergy/Nuclear12
FUEFuel/Gas/Oil12
SCIScience/Technology9

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 1262Mikaela Naylon Give Kids a Chance Act15
H.R. 946ORPHAN Cures Act10
S. 932Give Kids a Chance Act of 202510
H.R. 1An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.6
H.R. 1492To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…6
H.R. 1672Maintaining Investments in New Innovation Act6
S. 1096Preserve Access to Affordable Generics and Biosimilars Act5
S. 1097Interagency Patent Coordination and Improvement Act of 20255
S. 527Prescription Pricing for the People Act of 20255
H.R. 3152Patent Eligibility Restoration Act of 20254
H.R. 3160PREVAIL Act4
S. 1041Affordable Prescriptions for Patients Act4
S. 1095Stop STALLING Act4
S. 1546Patent Eligibility Restoration Act of 20254
S. 1553PREVAIL Act4
S. 2276ETHIC Act4
S. 2658Medication Affordability and Patent Integrity Act4
S. 43Skinny Labels, Big Savings Act4
S. 526Pharmacy Benefit Manager Transparency Act of 20254
S. 705Innovation in Pediatric Drugs Act of 20254
S. 864HELP Copays Act4
H.R. 5256340B ACCESS Act3
H.R. 6423HELP Copays Act3
H.R. 6485Skinny Labels, Big Savings Act3
S. 1302Increasing Transparency in Generic Drug Applications Act3

Lobbyists

Named on the filings.

LobbyistClientsFilings
AIKEN HACKETT116
AMBER MANKO116
DAVID LACHMANN116
ELISABETH FOX116
EMILY WHEELER116
KRISTIN MURPHY116
PHYLLIS ARTHUR116
ANNA ABRAM114
BILL GHENT114
BRENT DEL MONTE114
DANIEL FARMER114
HANSJORG SAUER114
JOEL BAILEY114
JOHN STONE114
REMY MASON114
ROBB WALTON114
SANDRA ALCALA114
STACEY ALEXANDER114
STEVEN ELMENDORF114
VIRGIL MILLER114
CAITLIN CANTER113
STEVEN PFRANG112
EMILY MICHAEL111
JOHN TORRES111
JUSTIN PINE111

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
BIOTECHNOLOGY INNOVATION ORGANIZATIONBIOTECHNOLOGY INNOVATION ORGANIZATION2026 second_quarter$2.4MJul 21, 2026
BIOTECHNOLOGY INNOVATION ORGANIZATIONAVOQ, LLC2026 second_quarter$80KJul 20, 2026
BIOTECHNOLOGY INNOVATION ORGANIZATIONBGR GOVERNMENT AFFAIRS2026 second_quarter$60KJul 20, 2026
BIOTECHNOLOGY INNOVATION ORGANIZATIONVALCOUR LLC2026 second_quarter$50KJul 20, 2026
BIOTECHNOLOGY INNOVATION ORGANIZATIONAKIN GUMP STRAUSS HAUER & FELD2026 second_quarter$60KJul 20, 2026
BIOTECHNOLOGY INNOVATION ORGANIZATIONDLA PIPER LLP (US)2026 second_quarter$60KJul 17, 2026
BIOTECHNOLOGY INNOVATION ORGANIZATIONAVOQ, LLC2026 first_quarter$80KApr 20, 2026
BIOTECHNOLOGY INNOVATION ORGANIZATIONVALCOUR LLC2026 first_quarter$50KApr 20, 2026
BIOTECHNOLOGY INNOVATION ORGANIZATIONBIOTECHNOLOGY INNOVATION ORGANIZATION2026 first_quarter$1.6MApr 20, 2026
BIOTECHNOLOGY INNOVATION ORGANIZATIONBGR GOVERNMENT AFFAIRS2026 first_quarter$60KApr 20, 2026
BIOTECHNOLOGY INNOVATION ORGANIZATIONAKIN GUMP STRAUSS HAUER & FELD2026 first_quarter$60KApr 20, 2026
BIOTECHNOLOGY INNOVATION ORGANIZATIONDLA PIPER LLP (US)2026 first_quarter$60KApr 20, 2026
BIOTECHNOLOGY INNOVATION ORGANIZATIONAVOQ, LLC2025 fourth_quarter$80KJan 20, 2026
BIOTECHNOLOGY INNOVATION ORGANIZATIONBIOTECHNOLOGY INNOVATION ORGANIZATION2025 fourth_quarter$1.5MJan 20, 2026
BIOTECHNOLOGY INNOVATION ORGANIZATIONVALCOUR LLC2025 fourth_quarter$50KJan 20, 2026
BIOTECHNOLOGY INNOVATION ORGANIZATIONBGR GOVERNMENT AFFAIRS2025 fourth_quarter$60KJan 20, 2026
BIOTECHNOLOGY INNOVATION ORGANIZATIONAKIN GUMP STRAUSS HAUER & FELD2025 fourth_quarter$60KJan 20, 2026
BIOTECHNOLOGY INNOVATION ORGANIZATIONDLA PIPER LLP (US)2025 fourth_quarter$60KJan 16, 2026
BIOTECHNOLOGY INNOVATION ORGANIZATIONAVOQ, LLC2025 third_quarter$80KOct 20, 2025
BIOTECHNOLOGY INNOVATION ORGANIZATIONBIOTECHNOLOGY INNOVATION ORGANIZATION2025 third_quarter$1.4MOct 20, 2025
BIOTECHNOLOGY INNOVATION ORGANIZATIONVALCOUR LLC2025 third_quarter$50KOct 20, 2025
BIOTECHNOLOGY INNOVATION ORGANIZATIONBGR GOVERNMENT AFFAIRS2025 third_quarter$60KOct 20, 2025
BIOTECHNOLOGY INNOVATION ORGANIZATIONAKIN GUMP STRAUSS HAUER & FELD2025 third_quarter$60KOct 20, 2025
BIOTECHNOLOGY INNOVATION ORGANIZATIONDLA PIPER LLP (US)2025 third_quarter$60KOct 16, 2025
BIOTECHNOLOGY INNOVATION ORGANIZATIONARENTFOX SCHIFF LLP2025 third_quarter—Oct 15, 2025